
641569-94-0 Nilotinib Intermediate
Product name:Benzoic acid,4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acidCAS:641569-94-0. MF:C17H14N4O2. MW:306.32. EINECS:629-968-8. MDL No.:MFCD11521324
Add to Inquiry
CAS 2861-28-1 | 3,4-(Methylenedioxy)phenylacetic Acid
Name: 3,4-(METHYLENEDIOXY) PHENYLACETIC ACIDCAS number: 2861-28-1Molecular formula: C9H8O4Molecular weight: 180.16EINECS number: 220-679-9MDL No.:MFCD00014576
Add to Inquiry
CAS 2639960-27-1 | Cbz-tert-butyl 4-amino-3,3-difluoropyrrolidine-1-carboxylate
Name: Cbz-tert-butyl 4-amino-3,3-difluoropyrrolidine-1-carboxylateCAS number: 2639960-27-1Molecular formula:Molecular weight: 356.37EINECS number:MDL No.:
Add to Inquiry
565456-77-1
Product name:Methyl (1R,2S,5S)-6,6-dimethyl-3-azabicyclo-[3.1.0]hexane-2-carboxylate hydrochlorideCAS:565456-77-1MF:C9H16ClNO2MW:205.68EINECS:611-400-5MDL No.:MFCD11865137
Add to Inquiry![943516-54-9 6,6-dimethyl-3-azabicyclo-[3.1.0]hexane](/uploads/41320/small/943516-54-97d6ba.jpg)
943516-54-9 6,6-dimethyl-3-azabicyclo-[3.1.0]hexane
CAS:943516-54-9MF:C7H13NMW:111.18EINECS:1308068-626-2MDL No.:MFCD13176114
Add to Inquiry
107884-32-2 Oxyfluorocyclic Ester
CAS:107884-32-2MF:C20H24FN3O4MW:389.42EINECS:MDL No.:MFCD13152034
Add to Inquiry
496-15-1 Indoline
Product name: IndolineCAS number: 496-15-1Molecular formula: C8H9NMolecular weight: 119.16EINECS number: 207-816-8MDL No.:MFCD00005705
Add to Inquiry
294855-91-7
Product name: (S) -5- (2,5-dioxyriridin-1-yl) oxy) -5-oxo-2-palmitamidopentanoid acidCAS number: 294855-91-7Molecular formula: C25H42N2O7Molecular weight: 482.61EINECS number:MDL No.:MFCD32695506
Add to Inquiry
90-33-5 4-Methylumbelliferone
Product name: 4-MethylumbelliferoneCAS number: 90-33-5Molecular formula: C10H8O3Molecular weight: 176.17EINECS number: 201-986-7MDL No.:MFCD00006866
Add to Inquiry
161596-47-0 N-(s)-glycidylphthalimide
CAS:161596-47-0. MF:C11H9NO3. MW:203.19. EINECS:454-720-9. MDL No.:MFCD04973350
Add to Inquiry
827026-45-9 4-nitro Lenalidomide
CAS:827026-45-9. MF:C13H11N3O5. MW:289.24. EINECS:1592732-453-0. MDL No.:MFCD11977267
Add to Inquiry
China Nilotinib intermediate Manufacturers Factory Suppliers
Relying on mass production and reliable quality, our alternative intermediate, cost effective intermediate, mainstream product intermediate is well-received in domestic and international markets and has gained a good reputation from our customers.We always adhere to the business philosophy of building a brand with quality, creating a future with integrity, based on quality, service as the core, and win-win as the goal, invest in the industry with unlimited enthusiasm, and focus on Nilotinib intermediatefor many years. Our team is made up of experienced professionals, with a shared commitment to excellence, innovation, and customer satisfaction. We insist on the basic guideline of customer-centeredness and take it as a long-term strategy. Our team is dedicated to delivering the highest standards of quality and value. Our products are designed to be versatile and adaptable to different industries and applications. We are committed to providing our employees with a safe and healthy work environment. We have a comprehensive distribution network to ensure wide reach.WEBNilotinib, an oral inhibitor of the tyrosine kinase activity of Abelson protein, is approved for the treatment of patients with newly diagnosed chronic myeloid leukemia (CML) in...
WEBJan 7, 2021 · In patients on treatment for >5 years, CVEs occurred more frequently among patients in the high-risk (nilotinib 300-mg twice-daily, 33.3%; nilotinib 400-mg twice...
WEBPublished: 07 January 2021. Chronic myelogenous leukemia. Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in...
WEBNilotinib is a transduction inhibitor that targets BCR-ABL, c-kit and PDGF, for the potential treatment of various leukemias, including chronic myeloid leukemia (CML). Mechanism...
WEBSep 4, 2018 · Nilotinib, an oral inhibitor of the tyrosine kinase activity of Abelson protein, is approved for the treatment of patients with newly...
WEBJun 17, 2010 · Nilotinib has been shown to be a more potent inhibitor of BCR-ABL than imatinib. We evaluated the efficacy and safety of...
